Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 5, 2008 7:32:02 PM CDT

Learn about Newser Points »

Back to the grid

Drug Giant Sues Red Cross Over ... Red Cross

Posted Aug 9, 07 10:52 AM CDT in US,  Business,  Science & Health    Editor's Choice

(Newser) – Pharmaceutical behemoth Johnson & Johnson has filed a lawsuit in federal court against the American Red Cross over its signature logo, the Wall Street Journal reports. The suit claims the humanitarian organization is violating the Johnson & Johnson trademark by licensing the signature red cross symbol to companies for use on products such as first aid kits.

The suit, which demands punitive damages and that all licensed products with the cross be destroyed, is "bizarre," the head of the American Red Cross said. "For a multi-billion-dollar drug company to claim that the Red Cross violated a criminal statute—simply so that J&J can make more money—is obscene."

Source Wall Street Journal

Editor Recommended

Red Cross vs Red Cross
  ()
Brad Shaffer keeps warm at the American Red Cross emergency shelter at the Kansas Expocentre, in Topeka, Kan., on Monday, May 7, 2007. Shaffer was evacuated from his house after a nearby creek overflowed...   (Associated Press)
  ()
prev    next
play

Threads (1 of 3)

Tags

lawsuit  • pharmaceutical companies  • Red Cross  • Johnson and Johnson  • American Red Cross  • logo  • Mark Everson


Loading...

Loading...

Related Threads: Pharma Misbehaving, Drug Companies, Really Large Lawsuits

Next story from this section »

Today's Most Popular


Other Home Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »